Dr. Vikram Prasad, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 775 South Grand Ave, Fowlerville, MI 48836 Phone: 517-223-7800 Fax: 517-223-7814 |
Dr. Norine Tracy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 E Van Riper Rd, Suite 100, Fowlerville, MI 48836 Phone: 517-223-7900 Fax: 517-223-7635 |
News Archive
Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.
As a Grammy Award-winning poet, J. Ivy is celebrated throughout pop culture for his performance poetry, motivational speaking and hip-hop collaborations. Currently, with his new book "Dear Father: Breaking the Cycle of Pain," he will be recognized by BlackDoctor.org with a Top Blacks in Healthcare award at their gala on April 30, 2015.
Bisexuality, often stigmatized, typically has been lumped with homosexuality in previous public health research. But when Indiana University scientists recently focused on the health issues and behaviors specific to behaviorally bisexual men and women, they found tremendous variety, and that commonly used labels, such as heterosexual and homosexual, can sometimes do more harm than good.
Ventana Medical Systems, Inc., a member of the Roche Group, today announced that it has entered into an agreement with Incyte Corporation to collaborate on the development of companion diagnostic tests for Incyte's oncology drug programs, beginning with the Incyte IDO1 inhibitor program.
If we were to compare the progression of cryopreservation technology during recent years, we would find that from 2004 to 2013 over a timeframe of a decade, there has been around a 2.5 times increase in the rate of frozen-thawed embryo transfers (FETs) that were reported to the Society for Assisted Reproductive Technology (SART). While the rate of fresh embryo transfers (ET) that were completed was the same.
› Verified 2 days ago